Episode
Episode 135: VTE Series - Management of Antiphospholipid Antibody Syndrome
- Published
- May 7, 2025
- Processing state
not_requested- Canonical source
- https://www.thefellowoncall.com/tfocpodcast/aplsmgmt
Actions
POST https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-135-vte-series-management-of-antiphospholipid-antibody-syndrome/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-135-vte-series-management-of-antiphospholipid-antibody-syndrome.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This week, we round out our discussion we started in our prior episode on APLS, this time focusing on management. Stick around until the end to hear Dan and Vivek battle it out about the optimal time to recommend APLS testing for your patients! If you have not done so already, we highly recommend you check out episode 134 (diagnosis of APLS) prior to jumping into this one! Episode contents: - What is the best choice of anticoagulant? - Is a higher INR better for warfarin? - Are DOACs acceptable options? - What is the optimal time to send APLS testing? **** Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast